Arlene A. Forastiere

Professor

1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1981 2019

Filter
Article
2019

GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion

Zhang, W., Williams, T. A., Bhagwath, A. S., Hiermann, J. S., Peacock, C. D., Watkins, D. N., Ding, P., Park, J. Y., Montgomery, E. A., Forastiere, A. A., Jie, C., Cantarel, B. L., Pham, T. H. & Wang, D. H., Jan 1 2019, In : Laboratory Investigation.

Research output: Contribution to journalArticle

Malignant Pleural Effusion
Esophagogastric Junction
Carcinoma
Cell Line
Neoplasms

PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma

Eze, N., Lee, J. W., Yang, D. H., Zhu, F., Neumeister, V., Sandoval-Schaefer, T., Mehra, R., Ridge, J. A., Forastiere, A. A., Chung, C. H. & Burtness, B., Apr 1 2019, In : Oral Oncology. 91, p. 69-78 10 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Epidermal Growth Factor Receptor
Cisplatin
Biomarkers
Placebos
2018
Population
Clinical Trials
Therapeutics
Carboplatin
Cisplatin

Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma

Yoon, H., Choudhary, A., Kosozi, R., Bali, G. S., Zaidi, A., Atasoy, A., Forastiere, A. A. & Forastiere, A. A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

irinotecan
Adenocarcinoma
Confidence Intervals
Fatigue
Therapeutics
Radiation Oncology
Medical Oncology
Evidence-Based Practice
Practice Guidelines
Squamous Cell Carcinoma
Laryngeal Neoplasms
Medical Oncology
Larynx
Practice Guidelines
2017

Radiation therapy for oropharyngeal squamous cell carcinoma: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based Clinical Practice guideline

Quon, H., Vapiwala, N., Forastiere, A. A., Kennedy, E. B., Adelstein, D. J., Boykin, H., Califano, J. A., Holsinger, F. C., Nussenbaum, B., Rosenthal, D. I., Siu, L. L. & Waldron, J. N., Dec 20 2017, In : Journal of Clinical Oncology. 35, 36, p. 4078-4090 13 p.

Research output: Contribution to journalArticle

Radiation Oncology
Medical Oncology
Evidence-Based Practice
Practice Guidelines
Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Marur, S. & Forastiere, A. A., Mar 1 2016, In : Mayo Clinic Proceedings. 91, 3, p. 386-396 11 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Epidemiology
Oropharyngeal Neoplasms
Squamous Cell Neoplasms
Oropharynx
2015

Organ preservation for advanced larynx cancer: Issues and outcomes

Forastiere, A. A., Weber, R. S. & Trotti, A., Oct 10 2015, In : Journal of Clinical Oncology. 33, 29, p. 3262-3268 7 p.

Research output: Contribution to journalArticle

Organ Preservation
Laryngeal Neoplasms
Laryngectomy
Induction Chemotherapy
Larynx

Patients and physicians can discuss costs of cancer treatment in the clinic

Kelly, R. J., Forde, P., Elnahal, S. M., Forastiere, A. A., Rosner, G. & Smith, T. J., Jul 1 2015, In : Journal of Oncology Practice. 11, 4, p. 308-312 5 p.

Research output: Contribution to journalArticle

Health Care Costs
Physicians
Costs and Cost Analysis
Neoplasms
Emotions

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation

Masica, D. L., Li, S., Douville, C., Manola, J., Ferris, R. L., Burtness, B., Forastiere, A. A., Koch, W. M., Chung, C. H. & Karchin, R., May 1 2015, In : Human Genetics. 134, 5, p. 497-507 11 p.

Research output: Contribution to journalArticle

Mutation
Survival
Disease-Free Survival
Carcinoma, squamous cell of head and neck
Tumor Suppressor Protein p53

Quality of care and short- and long-term outcomes of laryngeal cancer care in the elderly

Gourin, C., Starmer, H. M., Herbert, R. J., Frick, K., Forastiere, A. A., Quon, H., Eisele, D. W. & Dy, S. E., Oct 1 2015, In : Laryngoscope. 125, 10, p. 2323-2329 7 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Quality of Health Care
Odds Ratio
Squamous Cell Neoplasms
Airway Obstruction

Short-and long-term outcomes of laryngeal cancer care in the elderly

Gourin, C., Starmer, H. M., Herbert, R. J., Frick, K., Forastiere, A. A., Eisele, D. W. & Quon, H., Apr 1 2015, In : Laryngoscope. 125, 4, p. 924-933 10 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Odds Ratio
Deglutition Disorders
Pneumonia
Airway Obstruction

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Haigentz, M., Vermorken, J. B., Forastiere, A. A., Corry, J., Beitler, J. J., Strojan, P., Hartl, D. M., Rodrigo, J. P., Bradford, C. R., Rinaldo, A., Takes, R. P., Mendenhall, W. M., Shaha, A. R., Wolf, G. T. & Ferlito, A., Apr 1 2015, In : European Archives of Oto-Rhino-Laryngology. 272, 4, p. 781-787 7 p.

Research output: Contribution to journalArticle

2014

A 30-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Chung, C. H., Lee, J. W., Slebos, R. J., Howard, J. D., Perez, J., Kang, H., Fertig, E., Considine, M., Gilbert, J., Murphy, B. A., Nallur, S., Paranjape, T., Jordan, R. C., Garcia, J., Burtness, B., Forastiere, A. A. & Weidhaas, J. B., Nov 1 2014, In : Annals of Oncology. 25, 11, p. 2230-2236 7 p.

Research output: Contribution to journalArticle

Untranslated Regions
Cisplatin
Oropharynx
Platinum
Cell Line

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

Wanebo, H. J., Lee, J., Burtness, B. A., Ridge, J. A., Ghebremichael, M., Spencer, S. A., Psyrri, D., Pectasides, E., Rimm, D., Rosen, F. R., Hancock, M. R., Tolba, K. A. & Forastiere, A. A., Oct 1 2014, In : Annals of Oncology. 25, 10, p. 2036-2041 6 p.

Research output: Contribution to journalArticle

Carboplatin
Head and Neck Neoplasms
Paclitaxel
Biopsy
Survival

Phase II study of cetuximab in combination with cisplatin and radiation in Unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303

Marie Egloff, A., Lee, J. W., Langer, C. J., Quon, H., Vaezi, A., Grandis, J. R., Seethala, R. R., Wang, L., Shin, D. M., Argiris, A., Yang, D., Mehra, R., Andrew Ridge, J., Patel, U. A., Burtness, B. A. & Forastiere, A. A., Oct 1 2014, In : Clinical Cancer Research. 20, 19, p. 5041-5051 11 p.

Research output: Contribution to journalArticle

Cisplatin
Radiation
Survival
Disease-Free Survival
Radiotherapy

Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303

Psyrri, A., Lee, J. W., Pectasides, E., Vassilakopoulou, M., Kosmidis, E. K., Burtness, B. A., Rimm, D. L., Wanebo, H. J. & Forastiere, A. A., Jun 1 2014, In : Clinical Cancer Research. 20, 11, p. 3023-3032 10 p.

Research output: Contribution to journalArticle

Squamous Cell Neoplasms
Head and Neck Neoplasms
Disease-Free Survival
Biomarkers
Head

Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: An analysis of Eastern Cooperative Oncology Group trials

Argiris, A., Li, S., Ghebremichael, M., Egloff, A. M., Wang, L., Forastiere, A. A., Burtness, B. & Mehra, R., 2014, In : Annals of Oncology. 25, 7, p. 1410-1416 7 p., mdu167.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
irinotecan
Survival
docetaxel
In Situ Hybridization

Quality indicators of laryngeal cancer care in the elderly

Gourin, C., Frick, K., Blackford, A. L., Herbert, R. J., Quon, H., Forastiere, A. A., Eisele, D. W. & Dy, S. E., 2014, In : Laryngoscope. 124, 9, p. 2049-2056 8 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Quality of Health Care
Survival
Squamous Cell Neoplasms
Terminal Care

Treatment, survival, and costs of laryngeal cancer care in the elderly

Gourin, C., Dy, S. E., Herbert, R. J., Blackford, A. L., Quon, H., Forastiere, A. A., Eisele, D. W. & Frick, K., 2014, In : Laryngoscope. 124, 8, p. 1827-1835 9 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Health Care Costs
Survival
Costs and Cost Analysis
Confidence Intervals
2013

Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma

Strojan, P., Haigentz, M., Bradford, C. R., Wolf, G. T., Hartl, D. M., Langendijk, J. A., Rinaldo, A., Eisbruch, A., Mendenhall, W. M., Forastiere, A. A., Takes, R. P. & Ferlito, A., Apr 2013, In : Oral Oncology. 49, 4, p. 283-286 4 p.

Research output: Contribution to journalArticle

Combined Modality Therapy
Laryngectomy
Laryngeal Neoplasms
Chemoradiotherapy
Antineoplastic Agents

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): An open-label phase 3 randomised trial

Vermorken, J. B., Stöhlmacher-Williams, J., Davidenko, I., Licitra, L., Winquist, E., Villanueva, C., Foa, P., Rottey, S., Skladowski, K., Tahara, M., Pai, V. R., Faivre, S., Blajman, C. R., Forastiere, A. A., Stein, B. N., Oliner, K. S., Pan, Z. & Bach, B. A., Jul 2013, In : The Lancet Oncology. 14, 8, p. 697-710 14 p.

Research output: Contribution to journalArticle

Fluorouracil
Cisplatin
Control Groups
Survival
panitumumab

Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: A cooperative group correlative study

Roh, J. L., Wang, X. V., Manola, J., Sidransky, D., Forastiere, A. A. & Koch, W. M., May 1 2013, In : Clinical Cancer Research. 19, 9, p. 2528-2540 13 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Methylation
Genes
Neoplasms
Suppressor Genes
Alphapapillomavirus
Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
Oropharyngeal Neoplasms
Papillomavirus Infections

Induction chemotherapy meta-analysis in head and neck cancer: Right answer, wrong question

Forastiere, A. A., Adelstein, D. J. & Manola, J., Aug 10 2013, In : Journal of Clinical Oncology. 31, 23, p. 2844-2846 3 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Induction Chemotherapy
Head and Neck Neoplasms
Meta-Analysis

Is open surgery for head and neck cancers truly declining?

Hartl, D. M., Brasnu, D. F., Shah, J. P., Hinni, M. L., Takes, R. P., Olsen, K. D., Kowalski, L. P., Rodrigo, J. P., Strojan, P., Wolf, G. T., Rinaldo, A., Suárez, C., Mendenhall, W. M., Paleri, V., Forastiere, A. A., Werner, J. A. & Ferlito, A., Nov 2013, In : European Archives of Oto-Rhino-Laryngology. 270, 11, p. 2793-2802 10 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Neoplasms
Skull Base
Technology
Mouth

Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer

Forastiere, A. A., Zhang, Q., Weber, R. S., Maor, M. H., Goepfert, H., Pajak, T. F., Morrison, W., Glisson, B., Trotti, A., Ridge, J. A., Thorstad, W., Wagner, H., Ensley, J. F. & Cooper, J. S., Mar 1 2013, In : Journal of Clinical Oncology. 31, 7, p. 845-852 8 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Larynx
Radiotherapy
Therapeutics
Cisplatin
irinotecan
Proteasome Inhibitors
Arm
Head and Neck Neoplasms
Bortezomib

Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: An eastern cooperative oncology group trial

Argiris, A., Ghebremichael, M., Gilbert, J., Lee, J. W., Sachidanandam, K., Kolesar, J. M., Burtness, B. & Forastiere, A. A., Apr 10 2013, In : Journal of Clinical Oncology. 31, 11, p. 1405-1414 10 p.

Research output: Contribution to journalArticle

docetaxel
Head and Neck Neoplasms
Randomized Controlled Trials
Placebos
Epidermal Growth Factor Receptor

Reply to E.G. Russi et al and R. Haddad

Forastiere, A. A., Zhang, Q., Weber, R. S. & Ridge, J. A., Sep 1 2013, In : Journal of Clinical Oncology. 31, 25, p. 3171 1 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
2012

A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck

Gilbert, J., Rudek-Renaut, M., Higgins, M. J., Zhao, M., Bienvenu, S., Tsottles, N., Wahl, R., Forastiere, A. A. & Gillison, M., Mar 15 2012, In : Clinical Cancer Research. 18, 6, p. 1735-1742 8 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Cisplatin
Radiotherapy
Maximum Tolerated Dose
Epidermal Growth Factor Receptor

Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))

Gilbert, J., Rudek-Renaut, M., Higgins, M. J., Zhao, M., Bienvenu, S., Tsottles, N., Chaudhry, M. A., Wahl, R., Forastiere, A. A. & Gillison, M., Jul 15 2012, In : Clinical Cancer Research. 18, 14, p. 3998 1 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Head and Neck Neoplasms
Squamous Cell Carcinoma
Research
Erlotinib Hydrochloride

Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer

Sanguineti, G., Sormani, M. P., Marur, S., Gunn, G. B., Rao, N., Cianchetti, M., Ricchetti, F., McNutt, T., Wu, B. & Forastiere, A. A., May 1 2012, In : International Journal of Radiation Oncology, Biology, Physics. 83, 1, p. 235-242 8 p.

Research output: Contribution to journalArticle

Oropharyngeal Neoplasms
Mucositis
chemotherapy
radiation therapy
Radiotherapy

Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: An RTOG analysis

Machtay, M., Moughan, J., Farach, A., Martin-O'Meara, E., Galvin, J., Garden, A. S., Weber, R. S., Cooper, J. S., Forastiere, A. A. & Ang, K. K., Nov 15 2012, In : International Journal of Radiation Oncology, Biology, Physics. 84, 4, p. 983-989 7 p.

Research output: Contribution to journalArticle

Radiation Oncology
Head and Neck Neoplasms
toxicity
radiation therapy
Radiotherapy

Long-term follow-up of the RTOG 9501/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck

Cooper, J. S., Zhang, Q., Pajak, T. F., Forastiere, A. A., Jacobs, J., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., Lustig, R., Ensley, J. F., Thorstad, W., Schultz, C. J., Yom, S. S. & Ang, K. K., Dec 1 2012, In : International Journal of Radiation Oncology, Biology, Physics. 84, 5, p. 1198-1205 8 p.

Research output: Contribution to journalArticle

chemotherapy
radiation therapy
Radiotherapy
cancer
Drug Therapy

Reply to D.C. Gilbert et al

Mroz, E. A., Forastiere, A. A. & Rocco, J. W., Mar 10 2012, In : Journal of Clinical Oncology. 30, 8, p. 891-892 2 p.

Research output: Contribution to journalArticle

Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia

Adelstein, D. J., Ridge, J. A., Brizel, D. M., Holsinger, F. C., Haughey, B. H., O'Sullivan, B., Genden, E. M., Beitler, J. J., Weinstein, G. S., Quon, H., Chepeha, D. B., Ferris, R. L., Weber, R. S., Movsas, B., Waldron, J., Lowe, V., Ramsey, S., Manola, J., Yueh, B., Carey, T. E. & 7 others, Bekelman, J. E., Konski, A. A., Moore, E., Forastiere, A. A., Schuller, D. E., Lynn, J. & Ullmann, C. D., Dec 2012, In : Head and Neck. 34, 12, p. 1681-1703 23 p.

Research output: Contribution to journalArticle

Pharyngeal Neoplasms
National Cancer Institute (U.S.)
Head and Neck Neoplasms
Clinical Trials
Oropharyngeal Neoplasms

Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy

Sanguineti, G., Ricchetti, F., Wu, B., Agrawal, N., Gourin, C., Agbahiwe, H., Marur, S., Clemente, S., McNutt, T. & Forastiere, A. A., Nov 2012, In : Head and Neck. 34, 11, p. 1640-1647 8 p.

Research output: Contribution to journalArticle

Neck
Radiotherapy
Lymph Nodes
Therapeutics
Drug Therapy
2011

Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

Kurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., Hong, D. S., Ng, C. S., Ye, L., Gagel, R. F., Frye, J., Müller, T., Ratain, M. J. & Salgia, R., Jul 1 2011, In : Journal of Clinical Oncology. 29, 19, p. 2660-2666 7 p.

Research output: Contribution to journalArticle

Protein-Tyrosine Kinases
Vascular Endothelial Growth Factor Receptor-2
Mucositis
Maximum Tolerated Dose
cabozantinib

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)

Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R. S., Deconti, R. C. & Forastiere, A. A., Aug 1 2011, In : Cancer. 117, 15, p. 3374-3382 9 p.

Research output: Contribution to journalArticle

Adenoid Cystic Carcinoma
Doxorubicin
Neck
Head
Bortezomib

Erratum: Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care (Laryngoscope (2011) 121 (85-90))

Gourin, C., Forastiere, A. A., Sanguineti, G., Koch, W. M., Marur, S. & Bristow, R. E., Feb 2011, In : Laryngoscope. 121, 2, p. 457 1 p.

Research output: Contribution to journalArticle

Laryngoscopes
Laryngeal Neoplasms
Costs and Cost Analysis
Surgeons

Feasibility of economic analysis of radiation therapy oncology group (RTOG) 91-11 using medicare data

Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Forastiere, A. A., Ang, K. K. & Watkins-Bruner, D., Feb 1 2011, In : International Journal of Radiation Oncology, Biology, Physics. 79, 2, p. 436-442 7 p.

Research output: Contribution to journalArticle

economic analysis
Radiation Oncology
Medicare
radiation therapy
Radiotherapy

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: A retrospective cohort study of the Eastern Cooperative Oncology Group

Yoon, H. H., Catalano, P. J., Murphy, K. M., Skaar, T. C., Philips, S., Powell, M., Montgomery, E. A., Hafez, M. J., Offer, S. M., Liu, G., Meltzer, S., Wu, X., Forastiere, A. A., Benson, A. B., Kleinberg, L. R. & Gibson, M. K., May 17 2011, In : BMC Cancer. 11, 176.

Research output: Contribution to journalArticle

Chemoradiotherapy
DNA Repair
Single Nucleotide Polymorphism
Adenocarcinoma
Cohort Studies

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: Results from the Eastern Cooperative Oncology Group

Yoon, H. H., Catalano, P., Gibson, M. K., Skaar, T. C., Philips, S., Montgomery, E. A., Hafez, M. J., Powell, M., Liu, G., Forastiere, A. A., Benson, A. B., Kleinberg, L. R. & Murphy, K. M., Oct 2011, In : Cancer Chemotherapy and Pharmacology. 68, 4, p. 863-870 8 p.

Research output: Contribution to journalArticle

Oncology
Chemoradiotherapy
Platinum
Cisplatin
Toxicity

Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials

Dilling, T. J., Bae, K., Paulus, R., Watkins-Bruner, D., Garden, A. S., Forastiere, A. A., Kian Ang, K. & Movsas, B., Nov 1 2011, In : International Journal of Radiation Oncology, Biology, Physics. 81, 3

Research output: Contribution to journalArticle

Radiation Oncology
Head and Neck Neoplasms
radiation therapy
Radiotherapy
cancer

Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care

Gourin, C., Forastiere, A. A., Sanguineti, G., Koch, W. M., Marur, S. & Bristow, R. E., Jan 2011, In : Laryngoscope. 121, 1, p. 85-90 6 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Costs and Cost Analysis
Linear Models
Length of Stay
Hospital Costs

Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care

Gourin, C., Forastiere, A. A., Sanguineti, G., Marur, S., Koch, W. M. & Bristow, R. E., Apr 2011, In : Laryngoscope. 121, 4, p. 746-752 7 p.

Research output: Contribution to journalArticle

Oropharyngeal Neoplasms
Costs and Cost Analysis
Hospital Costs
Diagnosis-Related Groups
Health Care Costs

Implications of the oropharyngeal cancer epidemic

Mroz, E. A., Forastiere, A. A. & Rocco, J. W., Nov 10 2011, In : Journal of Clinical Oncology. 29, 32, p. 4222-4223 2 p.

Research output: Contribution to journalArticle

Papillomaviridae
Oropharyngeal Neoplasms
Squamous Cell Carcinoma